Markets:

Overview

News

Currencies

International

Treasuries

iShares Biotechnology ETF (NQ:IBB)

174.13 -0.85 (-0.49%)

Streaming Delayed Price Updated: 3:09 PM EST, Feb 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about iShares Biotechnology ETF

< Previous 1 2 3 4 5 6 7 8 9

...

27 28 Next >

AbbVie Stock: A Perfect Dip for Investors to Buy

July 03, 2024

ABBV stock is down over 3% to start the second half of the year; the stock may be overvalued in the short term but still offers value for long-term investors

Via MarketBeat

Topics ETFs

Tesla And Tech Are Still Taking The Bulls Higher ↗

July 02, 2024

While we’ve seen some compelling signs that the market is ready for new leadership, tech is still presenting problems for the bears.

Via Talk Markets

Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex

July 02, 2024

The biotech sector (IBB) is trading just 3% away from its 52-week high and a significant resistance level, suggesting a potential breakout.

Via MarketBeat

Topics ETFs

Top Performing Industry ETFs In June: Software Leads Returns, Chipmakers Attract Most Inflows ↗

July 01, 2024

June saw gains in the U.S. stock market, with tech and biotech leading the way. Semiconductor ETFs saw strong inflows, while utilities lagged.

Via Benzinga

Topics ETFs

Big Brother Biotechnology Sector Revives ↗

June 24, 2024

IBB sits just below the 200-WMA. Plus, he is in the middle of the weekly channel range. Furthermore, back in May, IBB handily cleared above the 50-WMA.

Via Talk Markets

U.S. Centric Indicators ↗

June 30, 2024

The big takeaway is that the public does not see a top in sight and is buying at what could be record highs, at least for a while.

Via Talk Markets

Rags to Riches: 3 Biotech Stocks That Could Make Early Investors Rich ↗

June 27, 2024

These three biotech stocks to buy carry risks but may appeal to speculative investors with time and patience.

Via InvestorPlace

Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for June 2024 ↗

June 26, 2024

Selecting strong buy biotech stocks isn’t easy when most of them don’t make money. Here are three possibilities to meet this challenge.

Via InvestorPlace

One Day Doth Not A Sector Rotation Make ↗

June 26, 2024

IWM remains an underperformer to the benchmark. Real Motion shows a bit of a bearish divergence. Let’s compare this to Nvidia

Via Talk Markets

Tech Is Consolidating And The Market’s Seeking New Leadership ↗

June 25, 2024

The tape tells the tale, just like it always does: The tech sector is clearly in consolidation mode right now.

Via Talk Markets

Weekly Visit With The Economy ↗

June 23, 2024

Via Talk Markets

Topics Economy

Want to Earn More in the Stock Market With Less Effort? Try This Simple Strategy ↗

June 22, 2024

You don't need to be a stock market expert to earn above-average returns.

Via The Motley Fool

Stocks Stall As Chip Sector Struggles To Rebound; Dollar Eyes 7-Week Peak, Gold, Bitcoin Retreat: What's Driving Markets Friday? ↗

June 21, 2024

Wall Street is experiencing a subdued and low volatility trading day Friday, despite the session coinciding with the “triple witching” day, with over $5.1 trillion of notional options exposure...

Via Benzinga

Gilead Sciences Stock Surges on HIV Treatment Trial Success

June 21, 2024

Gilead Sciences (NASDAQ: GILD) saw its stock jump nearly 10% yesterday after announcing groundbreaking results from its HIV treatment trial.

Via MarketBeat

Weekly Update - Sunday, June 16 ↗

June 16, 2024

Today, I want to get right down to the technical analysis with some actionable plans. It should not come as a surprise to see the indices diverge even further than where they have been over the last...

Via Talk Markets

Thoughts For Thursday: Tech Still Leading ↗

June 13, 2024

The stock market continued to pull higher Wednesday with the biggest points gained in the Nasdaq Composite. Tech is still the big leader.

Via Talk Markets

Topics Stocks

Large Cap BIopharmaceuticals Overview ↗

June 03, 2024

As a defensive play healthcare is weighted at about 12% of the S&P 500.

Via Talk Markets

Topics Stocks

Pay No Attention To That Tran Behind The Curtain? ↗

May 26, 2024

For the sake of redundancy and in case you are living under a rock and just came out to read my Daily, Nvidia (NVDA) and its ginormous beat on revenues, gave the market new life.

Via Talk Markets

Why the Rest of 2024 Could Be Good for Investing in Biotech Stocks ↗

May 24, 2024

Investors have been ignoring biotech stocks for far too long. Here's why they could start to heat up in 2024.

Via InvestorPlace

Large Cap Biopharmaceuticals Performance ↗

May 20, 2024

The biotech sector remains a laggard YTD as can be seen by the IBB.

Via Talk Markets

For Biotech Stocks To Move Higher, This Must Move Lower ↗

May 15, 2024

While biotechs have significantly lagged behind the broader market, there is reason to be optimistic once inflation-related volatility subsides. IBB and XBI present good vehicles for biotech exposure.

Via Talk Markets

Will the Biotech Sector Shift From Lagger to Leader?

May 10, 2024

The biotech sector has experienced a significant rally after bouncing off uptrend support and is now consolidating near major SMAs.

Via MarketBeat

Topics ETFs

Consumer Spending - Single Most Driving Force ↗

May 07, 2024

The choices we make as consumers collectively shape the economic landscape, and our spending patterns influence the well-being of our communities and the nation.

Via Talk Markets

Economic Modern Family-Tell Us a Story ↗

May 05, 2024

Taking a look at the markets and how to best prepare for the coming week.

Via Talk Markets

When Silver Looks Bad, It’s Been A Sign Of A Bottom ↗

April 30, 2024

Silver cleared $26 but for only 3 weeks. Then it gapped lower in early May 2023 and did not clear that level ($26) again for a year.

Via Talk Markets

April Showers On Wall Street: Miners, Utilities Emerge As Bright Spots In Gloomy Market ↗

April 30, 2024

Performance in April 2024: Utilities lead, real estate lags. S&P 500, Nasdaq 100, Dow Jones Industrial Average, small-cap and large-cap indices all decline.

Via Benzinga

Topics Stocks

Can Semiconductors Pull Off Another Sustained Rally? ↗

April 28, 2024

With all the news flying around, we have found incredible confidence in our trading strategies by following the technical picture.

Via Talk Markets

Quick Look At The Economic Modern Family ↗

April 23, 2024

While I am extremely focused on commodities as outlined in Monday’s Daily, my viewpoint for most equities remains cautious to neutral. What might turn us to be more bullish? Let’s analyze.

Via Talk Markets

Healthcare Stocks Are Lagging With Big Earnings Weeks Ahead ↗

April 16, 2024

Healthcare stocks disappointed again last week with the XLV down over 3% and up only 1.65 % YTD, in a continued downtrend since March 28.

Via Talk Markets

Massive Weekly Price Consolidation Will Show The Way ↗

April 08, 2024

Consolidation is one of our favorite chart patterns, especially when prices are consolidating at new highs or lows. The direction the price follows, up or down out of the consolidation can lead to...

Via Talk Markets

< Previous 1 2 3 4 5 6 7 8 9

...

27 28 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

iShares Biotechnology ETF (NQ:IBB)

All News about iShares Biotechnology ETF

Starting at $3.75/week.

Subscribe Today